
News|Videos|December 15, 2017
Treatment of Challenging Mantle Cell Lymphoma Cases
Author(s)Peter Martin, MD
This video reviews the treatment of mantle cell lymphoma cases that do not fit the typical mold.
Advertisement
In this video, Peter Martin, MD, of Weill Cornell Medicine in New York, discusses the treatment of mantle cell lymphoma cases that do not fit the typical mold.
Martin gave a presentation on this topic during an education session at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer
2
FDA ODAC Votes Yes to Capivasertib for PTEN-Deficient Metastatic HSPC
3
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
4
FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC
5


















































